Macular Degeneration Clinical Trials

A listing of Macular Degeneration medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UPDATED

Birmingham Alabama 35233

Patients are needed to participate in a clinical research study evaluating abicipar pegol, ranibizumab and sham procedure for the treatment of Macular Degeneration

UPDATED

Mobile Alabama

A Phase 2 clinical study for patients with Neovascular Age-Related Macular Degeneration

Mobile Alabama 36608

A Phase 3 clinical study for patients with Age-related Macular Degeneration (AMD)

Arizona

Gilbert Arizona 85295

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

UPDATED

Gilbert Arizona 85296

Patients are needed to participate in a clinical research study evaluating abicipar pegol, ranibizumab and sham procedure for the treatment of Macular Degeneration

Phoenix Arizona 85014

A clinical research study of Ranibizumab ITV injection and Ranibizumab through RPDS Implant for the treatment of Age-Related Macular Degeneration

Phoenix Arizona 85020

A clinical research study of Ranibizumab ITV injection and Ranibizumab through RPDS Implant for the treatment of Age-Related Macular Degeneration

Phoenix Arizona 85014

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

View More ▼

Phoenix Arizona 85020

A clinical trial to evaluate treatments using RG7716 and Ranibizumab for patients with Age-Related Macular Degeneration (AMD), Choroidal Neovascularization

Phoenix Arizona 85012

A clinical trial to evaluate treatments using RG7716 and Ranibizumab for patients with Age-Related Macular Degeneration (AMD), Choroidal Neovascularization

UPDATED

Phoenix Arizona

A Phase 2 clinical study for patients with Neovascular Age-Related Macular Degeneration

UPDATED

Phoenix Arizona

A Phase 2 clinical study for patients with Neovascular Age-Related Macular Degeneration

UPDATED

Phoenix Arizona

A Phase 2 clinical study for patients with Neovascular Age-Related Macular Degeneration

Phoenix Arizona 85020

A Phase 3 clinical study for patients with Age-related Macular Degeneration (AMD)

Phoenix Arizona 85021

A Phase 3 clinical study for patients with Age-related Macular Degeneration (AMD)

Phoenix Arizona 85014

A Phase 3 clinical study for patients with Age-related Macular Degeneration (AMD)

Phoenix Arizona 85020

A Phase 3 clinical study for patients with Geographic Atrophy

Phoenix Arizona 85014

A Phase 3 clinical study for patients with Geographic Atrophy

UPDATED

Phoenix Arizona 85021

A Phase 3 clinical study for patients with Macular Degeneration, Neovascular Age-related Macular Degeneration

UPDATED

Phoenix Arizona 85020

A Phase 3 clinical study for patients with Macular Degeneration, Neovascular Age-related Macular Degeneration

UPDATED

Phoenix Arizona 85014

A Phase 3 clinical study for patients with Macular Degeneration, Neovascular Age-related Macular Degeneration

UPDATED

Phoenix Arizona 85016

Patients are needed to participate in a clinical research study evaluating abicipar pegol, ranibizumab and sham procedure for the treatment of Macular Degeneration

UPDATED

Springdale Arizona 72764

Patients are needed to participate in a clinical research study evaluating abicipar pegol, ranibizumab and sham procedure for the treatment of Macular Degeneration

Tucson Arizona 85710

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Tucson Arizona 85704

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Tucson Arizona 85704

A clinical trial to evaluate treatments using RG7716 and Ranibizumab for patients with Age-Related Macular Degeneration (AMD), Choroidal Neovascularization

UPDATED

Tucson Arizona

A Phase 2 clinical study for patients with Neovascular Age-Related Macular Degeneration

UPDATED

Tucson Arizona

A Phase 2 clinical study for patients with Neovascular Age-Related Macular Degeneration

Tucson Arizona 85704

A Phase 3 clinical study for patients with Age-related Macular Degeneration (AMD)

UPDATED

Tucson Arizona 85710

A Phase 3 clinical study for patients with Macular Degeneration, Neovascular Age-related Macular Degeneration

UPDATED

Tucson Arizona 85704

Patients are needed to participate in a clinical research study evaluating abicipar pegol, ranibizumab and sham procedure for the treatment of Macular Degeneration

Arkansas

Springdale Arkansas 72764

A clinical trial to evaluate treatments using No Intervention for patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration (Proxima A)

California

Arcadia California

A clinical trial seeking patients for a research study for the treatment of Visual Acuity, Geographic Atrophy or Macular Degeneration (CNTO 2476)

Arcadia California

A clinical trial to evaluate treatments using DS-7080a and Ranibizumab for patients with Neovascular Age-Related Macular Degeneration

UPDATED

Arcadia California

A Phase 2 clinical study for patients with Neovascular Age-Related Macular Degeneration

Arcadia California 91007

A Phase 3 clinical study for patients with Age-related Macular Degeneration (AMD)

UPDATED

Arcadia California 91006

Patients are needed to participate in a clinical research study evaluating abicipar pegol, ranibizumab and sham procedure for the treatment of Macular Degeneration

View More ▼

UPDATED

Arcadia California 91007

Patients are needed to participate in a clinical research study evaluating abicipar pegol, ranibizumab and sham procedure for the treatment of Macular Degeneration

Bakersfield California 93309

A clinical research study of ranibizumab for the treatment of Age-Related Macular Degeneration

Bakersfield California 93309

A clinical trial to evaluate treatments using RG7716 and Ranibizumab for patients with Age-Related Macular Degeneration (AMD), Choroidal Neovascularization

UPDATED

Bakersfield California

A Phase 2 clinical study for patients with Neovascular Age-Related Macular Degeneration

Beverly Hills California 90211

A clinical trial seeking patients for a research study for the treatment of Dry Macular Degeneration or Geographic Atrophy

Beverly Hills California

A clinical trial to evaluate treatments using RG7716 and Ranibizumab for patients with Age-Related Macular Degeneration (AMD), Choroidal Neovascularization

UPDATED

Beverly Hills California

A Phase 2 clinical study for patients with Neovascular Age-Related Macular Degeneration

Beverly Hills California 90211

A Phase 2 clinical study for patients with Neovascular Age-Related Macular Degeneration

Beverly Hills California 90211

A Phase 3 clinical study for patients with Age-related Macular Degeneration (AMD)

Beverly Hills California

A Phase 3 clinical study for patients with Geographic Atrophy

Beverly Hills California 90211

Patients are needed to participate in a clinical research study of Intravitreal aflibercept injection and Placebo to evaluate Age-Related Macular Degeneration

Campbell California 95008

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Campbell California 95008

A Phase 3 clinical study for patients with Age-related Macular Degeneration (AMD)